Mohamed Elagawany

7PUBLICATIONS
17CO-AUTHORS
Molecular targetsGene and molecular therapyBiomolecular modelling and designCheminformatics and quantitative structure-activity relationshipsPowder and particle technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 25, 2026
Discovery of Imine-Modified Quinazolinyl Sulfonamides as Dual hCA IX/XII Inhibitors with Potent Antiproliferative Activity.

|Dec 31, 2025
Discovery of Novel Piperidinyl-Based Benzoxazole Derivatives as Anticancer Agents Targeting VEGFR-2 and c-Met Kinases.

Wagdy M Eldehna, Zainab M Elsayed, Mohamed R Elnagar

|Dec 23, 2025
Discovery of BE2012, a First-in-Class REV-ERBα/β Antagonist with Favorable Selectivity and Pharmacokinetics, and In Vivo Efficacy in Inducing Key Myogenic Factors for Muscle Repair upon Acute Muscle Injury.

Lingaiah Maram, Aurore-Cecile Valfort, Mohammad Homaidur Rahman

|Jul 28, 2025
Identification of Novel Triazole-Pyrazole Conjugates as Potential Anticonvulsant Agents: Synthesis and Biological Evaluations.

Wagdy M Eldehna, Mahmoud Abdelrahman Alkabbani, Zainab M Elsayed

|Aug 01, 2022
Ligand-based design, synthesis, computational insights, and in vitro studies of novel N-(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease.

Mohamed Elagawany, Ayman Abo Elmaaty, Ahmed Mostafa

|May 12, 2019
Baclofen impurities: Facile synthesis and novel environmentally benign chromatographic method for their simultaneous determination in baclofen.

Mohamed Elagawany, Nehal F Farid, Bahaa Elgendy

Pageof 2

Frequent Collaborators

2 joint publications

Wagdy M Eldehna

2 joint publications

Haytham O Tawfik

2 joint publications

Lamees Hegazy

2 joint publications

Bahaa Elgendy